Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2021	$ 2,000	$ 195,881,000	$ 0	$ 0	$ (55,186,000)	$ 140,697,000
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2021	23,205,915
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock	$ 0	4,000	0	0	0	4,000
Vesting of restricted common stock (in shares)	7,890
Issuance of common stock upon stock option exercises	$ 0	19,000	0	0	0	$ 19,000
Issuance of common stock upon stock option exercises (in shares)	44,105					44,105
Stock-based compensation	$ 0	1,464,000	0	0	0	$ 1,464,000
Vesting of restricted stock units, net of withholding	$ 0	0	(25,000)	0	0	(25,000)
Vesting of restricted stock units, net of withholding (in shares)	31,154
Unrealized gain (loss) on marketable securities	$ 0	0	0	(275,000)	0	(275,000)
Net loss	0	0	0	0	(37,201,000)	(37,201,000)
Stockholders equity, Ending balance at Jun. 30, 2022	$ 2,000	197,368,000	(25,000)	(275,000)	(92,387,000)	104,683,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2022	23,289,064
Stockholders equity, Beginning balance at Mar. 31, 2022	$ 2,000	196,529,000	0	(204,000)	(72,461,000)	123,866,000
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2022	23,253,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock	$ 0	2,000	0	0	0	2,000
Vesting of restricted common stock (in shares)	3,944
Stock-based compensation	$ 0	837,000	0	0	0	837,000
Stock based compensation (in shares)	0
Vesting of restricted stock units, net of withholding	$ 0	0	(25,000)	0	0	(25,000)
Vesting of restricted stock units, net of withholding (in shares)	31,154
Unrealized gain (loss) on marketable securities	$ 0	0	0	(71,000)	0	(71,000)
Net loss	0	0	0	0	(19,926,000)	(19,926,000)
Stockholders equity, Ending balance at Jun. 30, 2022	$ 2,000	197,368,000	(25,000)	(275,000)	(92,387,000)	104,683,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2022	23,289,064
Stockholders equity, Beginning balance at Dec. 31, 2022	$ 2,000	199,492,000	(35,000)	(161,000)	(150,266,000)	49,032,000
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2022	23,312,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock	$ 0	1,000	0	0	0	1,000
Vesting of restricted common stock (in shares)	3,946
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 2,000	46,501,000	0	0	0	46,503,000
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	17,810,000
Issuance of common stock upon stock option exercises	$ 0	1,466,000	0	0	0	$ 1,466,000
Issuance of common stock upon stock option exercises (in shares)	1,239,899					1,239,899
Stock-based compensation	$ 0	2,208,000	0	0	0	$ 2,208,000
Stock based compensation (in shares)	0
Vesting of restricted stock units, net of withholding	$ 0	0	(19,000)	0	0	(19,000)
Vesting of restricted stock units, net of withholding (in shares)	15,578
Unrealized gain (loss) on marketable securities	$ 0	0	0	159,000	0	159,000
Net loss	0	0	0	0	(27,169,000)	(27,169,000)
Stockholders equity, Ending balance at Jun. 30, 2023	$ 4,000	249,668,000	(54,000)	(2,000)	(177,435,000)	72,181,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2023	42,381,952
Stockholders equity, Beginning balance at Mar. 31, 2023	$ 2,000	201,185,000	(47,000)	(51,000)	(167,325,000)	33,764,000
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2023	23,786,337
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs	$ 2,000	46,501,000	0	0	0	46,503,000
Issuance of common stock, purchase warrants and pre-funded warrants for the purchase of common stock, net of underwriting discounts, commissions and offering costs (in shares)	17,810,000
Issuance of common stock upon stock option exercises	$ 0	1,238,000	0	0	0	1,238,000
Issuance of common stock upon stock option exercises (in shares)	777,826
Stock-based compensation	$ 0	744,000	0	0	0	744,000
Stock based compensation (in shares)	0
Vesting of restricted stock units, net of withholding	$ 0	0	(7,000)	0	0	(7,000)
Vesting of restricted stock units, net of withholding (in shares)	7,789
Unrealized gain (loss) on marketable securities	$ 0	0	0	49,000	0	49,000
Net loss	0	0	0	0	(10,110,000)	(10,110,000)
Stockholders equity, Ending balance at Jun. 30, 2023	$ 4,000	$ 249,668,000	$ (54,000)	$ (2,000)	$ (177,435,000)	$ 72,181,000
Stockholders equity, Ending balance (in shares) at Jun. 30, 2023	42,381,952